Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves

Reducing rates of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is important for achieving the best procedural outcomes. The cusp overlap technique (COT) implements procedural steps including an overlap angulation of the right and left coronary cusp to m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EuroIntervention 2023-06, Vol.19 (2), p.e176-e187
Hauptverfasser: Wienemann, Hendrik, Maier, Oliver, Beyer, Martin, Portratz, Max, Tanaka, Tetsu, Mauri, Victor, Ernst, Angela, Waldschmidt, Lara, Kuhn, Elmar, Bleiziffer, Sabine, Wilde, Nihal, Schaefer, Andreas, Zeus, Tobias, Baldus, Stephan, Zimmer, Sebastian, Veulemans, Verena, Rudolph, Tanja Katharina, Adam, Matti
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e187
container_issue 2
container_start_page e176
container_title EuroIntervention
container_volume 19
creator Wienemann, Hendrik
Maier, Oliver
Beyer, Martin
Portratz, Max
Tanaka, Tetsu
Mauri, Victor
Ernst, Angela
Waldschmidt, Lara
Kuhn, Elmar
Bleiziffer, Sabine
Wilde, Nihal
Schaefer, Andreas
Zeus, Tobias
Baldus, Stephan
Zimmer, Sebastian
Veulemans, Verena
Rudolph, Tanja Katharina
Adam, Matti
description Reducing rates of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is important for achieving the best procedural outcomes. The cusp overlap technique (COT) implements procedural steps including an overlap angulation of the right and left coronary cusp to mitigate this complication. We investigated the incidence of PPI and complication rates following the COT compared to the standard three-cusp implantation technique (3CT) in an all-comers cohort. A total of 2,209 patients underwent TAVI with the self-expanding Evolut platform from January 2016 to April 2022 at five sites. Baseline, procedural and in-hospital outcome characteristics were compared for both techniques before and after one-to-one propensity score matching. A total of 1,151 patients were implanted using the 3CT and 1,058 using the COT. At discharge, the rates of PPI (17.0 vs 12.3%; p=0.002) and moderate/severe paravalvular regurgitation (4.6% vs 2.4%; p=0.006) were significantly reduced with the COT compared with 3CT within the unmatched cohort. Overall procedural success and complication rates were similar; major bleeding was less common in the COT group (7.0% vs 4.6%; p=0.020). These results remained consistent after propensity score matching. In multivariable logistic regression analysis, right bundle branch block (odds ratio [OR] 7.19, 95% confidence interval [CI]: 5.18-10.0; p
doi_str_mv 10.4244/EIJ-D-22-01030
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10240731</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37013922</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-2e4582042b92392251ebf209c3e26878edc309a33b743fa3db50e47b7c35440c3</originalsourceid><addsrcrecordid>eNpVkM1OwzAQhC0EoqVw5Yj8Ai7-S5OcEGoLFFXiAmfLcTZNUJoE24ng7XEpVOW0K-3M7OhD6JrRqeRS3i5Xz2RBOCeUUUFP0Jils5TMOBOnR_sIXTj3TqlMKIvP0UjElImU8zHazHvX4XYAW-sOh-F6h53XTa5tjn1pAYjZSTyYsqk-esBFa7GDuiDw2QVd1Wzwcmjr3mNvdeOM9iV4sFi31lcGD7oewF2is0LXDq5-5wS9PSxf509k_fK4mt-viRER84SDjBJOJc9SvisYMcgKTlMjgM-SOIHcCJpqIbJYikKLPIsoyDiLg11KasQE3e1zuz7bBjU0oVStOltttf1Sra7U_0tTlWrTDopRLmksWEiY7hOMbZ2zUBzMjKodcxWYq4XiXP0wD4ab45cH-R9k8Q3eIX-e</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves</title><source>MEDLINE</source><source>PubMed Central</source><creator>Wienemann, Hendrik ; Maier, Oliver ; Beyer, Martin ; Portratz, Max ; Tanaka, Tetsu ; Mauri, Victor ; Ernst, Angela ; Waldschmidt, Lara ; Kuhn, Elmar ; Bleiziffer, Sabine ; Wilde, Nihal ; Schaefer, Andreas ; Zeus, Tobias ; Baldus, Stephan ; Zimmer, Sebastian ; Veulemans, Verena ; Rudolph, Tanja Katharina ; Adam, Matti</creator><creatorcontrib>Wienemann, Hendrik ; Maier, Oliver ; Beyer, Martin ; Portratz, Max ; Tanaka, Tetsu ; Mauri, Victor ; Ernst, Angela ; Waldschmidt, Lara ; Kuhn, Elmar ; Bleiziffer, Sabine ; Wilde, Nihal ; Schaefer, Andreas ; Zeus, Tobias ; Baldus, Stephan ; Zimmer, Sebastian ; Veulemans, Verena ; Rudolph, Tanja Katharina ; Adam, Matti</creatorcontrib><description>Reducing rates of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is important for achieving the best procedural outcomes. The cusp overlap technique (COT) implements procedural steps including an overlap angulation of the right and left coronary cusp to mitigate this complication. We investigated the incidence of PPI and complication rates following the COT compared to the standard three-cusp implantation technique (3CT) in an all-comers cohort. A total of 2,209 patients underwent TAVI with the self-expanding Evolut platform from January 2016 to April 2022 at five sites. Baseline, procedural and in-hospital outcome characteristics were compared for both techniques before and after one-to-one propensity score matching. A total of 1,151 patients were implanted using the 3CT and 1,058 using the COT. At discharge, the rates of PPI (17.0 vs 12.3%; p=0.002) and moderate/severe paravalvular regurgitation (4.6% vs 2.4%; p=0.006) were significantly reduced with the COT compared with 3CT within the unmatched cohort. Overall procedural success and complication rates were similar; major bleeding was less common in the COT group (7.0% vs 4.6%; p=0.020). These results remained consistent after propensity score matching. In multivariable logistic regression analysis, right bundle branch block (odds ratio [OR] 7.19, 95% confidence interval [CI]: 5.18-10.0; p&lt;0.001) and diabetes mellitus (OR 1.38, 95% CI: 1.05-1.80; p=0.021) emerged as predictors of PPI, whereas the COT (OR 0.63, 95% CI: 0.49-0.82; p&lt;0.001) was protective. The introduction of the COT was associated with a significant and relevant reduction of PPI and paravalvular regurgitation rates without an increase in complication rates.</description><identifier>ISSN: 1969-6213</identifier><identifier>ISSN: 1774-024X</identifier><identifier>EISSN: 1969-6213</identifier><identifier>DOI: 10.4244/EIJ-D-22-01030</identifier><identifier>PMID: 37013922</identifier><language>eng</language><publisher>France: Europa Edition</publisher><subject>Aortic Valve - surgery ; Aortic Valve Stenosis ; Aortic Valve Stenosis - surgery ; Clinical Research ; Heart Valve Prosthesis ; Humans ; Pacemaker, Artificial ; Permanent Pacemaker Implantation ; Postoperative Complications - epidemiology ; Prosthesis Design ; Risk Factors ; Transcatheter Aortic Valve Implantation ; Transcatheter Aortic Valve Replacement - adverse effects ; Transcatheter Aortic Valve Replacement - methods ; Treatment Outcome</subject><ispartof>EuroIntervention, 2023-06, Vol.19 (2), p.e176-e187</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351t-2e4582042b92392251ebf209c3e26878edc309a33b743fa3db50e47b7c35440c3</citedby><cites>FETCH-LOGICAL-c351t-2e4582042b92392251ebf209c3e26878edc309a33b743fa3db50e47b7c35440c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240731/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240731/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37013922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wienemann, Hendrik</creatorcontrib><creatorcontrib>Maier, Oliver</creatorcontrib><creatorcontrib>Beyer, Martin</creatorcontrib><creatorcontrib>Portratz, Max</creatorcontrib><creatorcontrib>Tanaka, Tetsu</creatorcontrib><creatorcontrib>Mauri, Victor</creatorcontrib><creatorcontrib>Ernst, Angela</creatorcontrib><creatorcontrib>Waldschmidt, Lara</creatorcontrib><creatorcontrib>Kuhn, Elmar</creatorcontrib><creatorcontrib>Bleiziffer, Sabine</creatorcontrib><creatorcontrib>Wilde, Nihal</creatorcontrib><creatorcontrib>Schaefer, Andreas</creatorcontrib><creatorcontrib>Zeus, Tobias</creatorcontrib><creatorcontrib>Baldus, Stephan</creatorcontrib><creatorcontrib>Zimmer, Sebastian</creatorcontrib><creatorcontrib>Veulemans, Verena</creatorcontrib><creatorcontrib>Rudolph, Tanja Katharina</creatorcontrib><creatorcontrib>Adam, Matti</creatorcontrib><title>Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves</title><title>EuroIntervention</title><addtitle>EuroIntervention</addtitle><description>Reducing rates of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is important for achieving the best procedural outcomes. The cusp overlap technique (COT) implements procedural steps including an overlap angulation of the right and left coronary cusp to mitigate this complication. We investigated the incidence of PPI and complication rates following the COT compared to the standard three-cusp implantation technique (3CT) in an all-comers cohort. A total of 2,209 patients underwent TAVI with the self-expanding Evolut platform from January 2016 to April 2022 at five sites. Baseline, procedural and in-hospital outcome characteristics were compared for both techniques before and after one-to-one propensity score matching. A total of 1,151 patients were implanted using the 3CT and 1,058 using the COT. At discharge, the rates of PPI (17.0 vs 12.3%; p=0.002) and moderate/severe paravalvular regurgitation (4.6% vs 2.4%; p=0.006) were significantly reduced with the COT compared with 3CT within the unmatched cohort. Overall procedural success and complication rates were similar; major bleeding was less common in the COT group (7.0% vs 4.6%; p=0.020). These results remained consistent after propensity score matching. In multivariable logistic regression analysis, right bundle branch block (odds ratio [OR] 7.19, 95% confidence interval [CI]: 5.18-10.0; p&lt;0.001) and diabetes mellitus (OR 1.38, 95% CI: 1.05-1.80; p=0.021) emerged as predictors of PPI, whereas the COT (OR 0.63, 95% CI: 0.49-0.82; p&lt;0.001) was protective. The introduction of the COT was associated with a significant and relevant reduction of PPI and paravalvular regurgitation rates without an increase in complication rates.</description><subject>Aortic Valve - surgery</subject><subject>Aortic Valve Stenosis</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Clinical Research</subject><subject>Heart Valve Prosthesis</subject><subject>Humans</subject><subject>Pacemaker, Artificial</subject><subject>Permanent Pacemaker Implantation</subject><subject>Postoperative Complications - epidemiology</subject><subject>Prosthesis Design</subject><subject>Risk Factors</subject><subject>Transcatheter Aortic Valve Implantation</subject><subject>Transcatheter Aortic Valve Replacement - adverse effects</subject><subject>Transcatheter Aortic Valve Replacement - methods</subject><subject>Treatment Outcome</subject><issn>1969-6213</issn><issn>1774-024X</issn><issn>1969-6213</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1OwzAQhC0EoqVw5Yj8Ai7-S5OcEGoLFFXiAmfLcTZNUJoE24ng7XEpVOW0K-3M7OhD6JrRqeRS3i5Xz2RBOCeUUUFP0Jils5TMOBOnR_sIXTj3TqlMKIvP0UjElImU8zHazHvX4XYAW-sOh-F6h53XTa5tjn1pAYjZSTyYsqk-esBFa7GDuiDw2QVd1Wzwcmjr3mNvdeOM9iV4sFi31lcGD7oewF2is0LXDq5-5wS9PSxf509k_fK4mt-viRER84SDjBJOJc9SvisYMcgKTlMjgM-SOIHcCJpqIbJYikKLPIsoyDiLg11KasQE3e1zuz7bBjU0oVStOltttf1Sra7U_0tTlWrTDopRLmksWEiY7hOMbZ2zUBzMjKodcxWYq4XiXP0wD4ab45cH-R9k8Q3eIX-e</recordid><startdate>20230605</startdate><enddate>20230605</enddate><creator>Wienemann, Hendrik</creator><creator>Maier, Oliver</creator><creator>Beyer, Martin</creator><creator>Portratz, Max</creator><creator>Tanaka, Tetsu</creator><creator>Mauri, Victor</creator><creator>Ernst, Angela</creator><creator>Waldschmidt, Lara</creator><creator>Kuhn, Elmar</creator><creator>Bleiziffer, Sabine</creator><creator>Wilde, Nihal</creator><creator>Schaefer, Andreas</creator><creator>Zeus, Tobias</creator><creator>Baldus, Stephan</creator><creator>Zimmer, Sebastian</creator><creator>Veulemans, Verena</creator><creator>Rudolph, Tanja Katharina</creator><creator>Adam, Matti</creator><general>Europa Edition</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20230605</creationdate><title>Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves</title><author>Wienemann, Hendrik ; Maier, Oliver ; Beyer, Martin ; Portratz, Max ; Tanaka, Tetsu ; Mauri, Victor ; Ernst, Angela ; Waldschmidt, Lara ; Kuhn, Elmar ; Bleiziffer, Sabine ; Wilde, Nihal ; Schaefer, Andreas ; Zeus, Tobias ; Baldus, Stephan ; Zimmer, Sebastian ; Veulemans, Verena ; Rudolph, Tanja Katharina ; Adam, Matti</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-2e4582042b92392251ebf209c3e26878edc309a33b743fa3db50e47b7c35440c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aortic Valve - surgery</topic><topic>Aortic Valve Stenosis</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Clinical Research</topic><topic>Heart Valve Prosthesis</topic><topic>Humans</topic><topic>Pacemaker, Artificial</topic><topic>Permanent Pacemaker Implantation</topic><topic>Postoperative Complications - epidemiology</topic><topic>Prosthesis Design</topic><topic>Risk Factors</topic><topic>Transcatheter Aortic Valve Implantation</topic><topic>Transcatheter Aortic Valve Replacement - adverse effects</topic><topic>Transcatheter Aortic Valve Replacement - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wienemann, Hendrik</creatorcontrib><creatorcontrib>Maier, Oliver</creatorcontrib><creatorcontrib>Beyer, Martin</creatorcontrib><creatorcontrib>Portratz, Max</creatorcontrib><creatorcontrib>Tanaka, Tetsu</creatorcontrib><creatorcontrib>Mauri, Victor</creatorcontrib><creatorcontrib>Ernst, Angela</creatorcontrib><creatorcontrib>Waldschmidt, Lara</creatorcontrib><creatorcontrib>Kuhn, Elmar</creatorcontrib><creatorcontrib>Bleiziffer, Sabine</creatorcontrib><creatorcontrib>Wilde, Nihal</creatorcontrib><creatorcontrib>Schaefer, Andreas</creatorcontrib><creatorcontrib>Zeus, Tobias</creatorcontrib><creatorcontrib>Baldus, Stephan</creatorcontrib><creatorcontrib>Zimmer, Sebastian</creatorcontrib><creatorcontrib>Veulemans, Verena</creatorcontrib><creatorcontrib>Rudolph, Tanja Katharina</creatorcontrib><creatorcontrib>Adam, Matti</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>EuroIntervention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wienemann, Hendrik</au><au>Maier, Oliver</au><au>Beyer, Martin</au><au>Portratz, Max</au><au>Tanaka, Tetsu</au><au>Mauri, Victor</au><au>Ernst, Angela</au><au>Waldschmidt, Lara</au><au>Kuhn, Elmar</au><au>Bleiziffer, Sabine</au><au>Wilde, Nihal</au><au>Schaefer, Andreas</au><au>Zeus, Tobias</au><au>Baldus, Stephan</au><au>Zimmer, Sebastian</au><au>Veulemans, Verena</au><au>Rudolph, Tanja Katharina</au><au>Adam, Matti</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves</atitle><jtitle>EuroIntervention</jtitle><addtitle>EuroIntervention</addtitle><date>2023-06-05</date><risdate>2023</risdate><volume>19</volume><issue>2</issue><spage>e176</spage><epage>e187</epage><pages>e176-e187</pages><issn>1969-6213</issn><issn>1774-024X</issn><eissn>1969-6213</eissn><abstract>Reducing rates of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is important for achieving the best procedural outcomes. The cusp overlap technique (COT) implements procedural steps including an overlap angulation of the right and left coronary cusp to mitigate this complication. We investigated the incidence of PPI and complication rates following the COT compared to the standard three-cusp implantation technique (3CT) in an all-comers cohort. A total of 2,209 patients underwent TAVI with the self-expanding Evolut platform from January 2016 to April 2022 at five sites. Baseline, procedural and in-hospital outcome characteristics were compared for both techniques before and after one-to-one propensity score matching. A total of 1,151 patients were implanted using the 3CT and 1,058 using the COT. At discharge, the rates of PPI (17.0 vs 12.3%; p=0.002) and moderate/severe paravalvular regurgitation (4.6% vs 2.4%; p=0.006) were significantly reduced with the COT compared with 3CT within the unmatched cohort. Overall procedural success and complication rates were similar; major bleeding was less common in the COT group (7.0% vs 4.6%; p=0.020). These results remained consistent after propensity score matching. In multivariable logistic regression analysis, right bundle branch block (odds ratio [OR] 7.19, 95% confidence interval [CI]: 5.18-10.0; p&lt;0.001) and diabetes mellitus (OR 1.38, 95% CI: 1.05-1.80; p=0.021) emerged as predictors of PPI, whereas the COT (OR 0.63, 95% CI: 0.49-0.82; p&lt;0.001) was protective. The introduction of the COT was associated with a significant and relevant reduction of PPI and paravalvular regurgitation rates without an increase in complication rates.</abstract><cop>France</cop><pub>Europa Edition</pub><pmid>37013922</pmid><doi>10.4244/EIJ-D-22-01030</doi></addata></record>
fulltext fulltext
identifier ISSN: 1969-6213
ispartof EuroIntervention, 2023-06, Vol.19 (2), p.e176-e187
issn 1969-6213
1774-024X
1969-6213
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10240731
source MEDLINE; PubMed Central
subjects Aortic Valve - surgery
Aortic Valve Stenosis
Aortic Valve Stenosis - surgery
Clinical Research
Heart Valve Prosthesis
Humans
Pacemaker, Artificial
Permanent Pacemaker Implantation
Postoperative Complications - epidemiology
Prosthesis Design
Risk Factors
Transcatheter Aortic Valve Implantation
Transcatheter Aortic Valve Replacement - adverse effects
Transcatheter Aortic Valve Replacement - methods
Treatment Outcome
title Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T22%3A54%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cusp%20overlap%20versus%20standard%20three-cusp%20technique%20for%20self-expanding%20Evolut%20transcatheter%20aortic%20valves&rft.jtitle=EuroIntervention&rft.au=Wienemann,%20Hendrik&rft.date=2023-06-05&rft.volume=19&rft.issue=2&rft.spage=e176&rft.epage=e187&rft.pages=e176-e187&rft.issn=1969-6213&rft.eissn=1969-6213&rft_id=info:doi/10.4244/EIJ-D-22-01030&rft_dat=%3Cpubmed_cross%3E37013922%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37013922&rfr_iscdi=true